AGXT Gene Hyperoxaluria Type 1 NGS Genetic DNA Test
Comprehensive Genetic Screening for Primary Hyperoxaluria
The AGXT Gene Hyperoxaluria Type 1 NGS Genetic DNA Test represents a breakthrough in metabolic disorder diagnostics, offering precise detection of genetic mutations responsible for primary hyperoxaluria type 1. This inherited condition affects the body’s ability to process glyoxylate, leading to excessive oxalate production that accumulates in kidneys and other organs. Early identification through this advanced genetic test enables proactive management strategies that can significantly improve patient outcomes and quality of life.
What This Test Measures and Detects
Our sophisticated NGS (Next-Generation Sequencing) technology comprehensively analyzes the AGXT gene to identify:
- Pathogenic variants in the alanine-glyoxylate aminotransferase gene
- Specific mutations affecting enzyme function in the liver
- Genetic markers associated with oxalate metabolism disorders
- Inheritance patterns for family planning decisions
- Risk assessment for kidney stone formation and renal complications
Who Should Consider This Genetic Test
This comprehensive screening is particularly recommended for individuals experiencing:
- Recurrent kidney stones, especially in childhood or adolescence
- Family history of primary hyperoxaluria or unexplained renal failure
- Elevated urinary oxalate levels without clear dietary causes
- Progressive renal impairment with unknown etiology
- Planning for pregnancy with family history of metabolic disorders
- Unexplained systemic oxalosis affecting multiple organs
Significant Benefits of Genetic Testing
Undergoing the AGXT Gene Hyperoxaluria Type 1 test provides numerous advantages:
- Early intervention opportunities before significant kidney damage occurs
- Personalized treatment plans based on specific genetic mutations
- Informed family planning and genetic counseling decisions
- Targeted dietary modifications to reduce oxalate accumulation
- Prevention of systemic oxalosis and multi-organ complications
- Access to emerging therapies and clinical trial opportunities
Understanding Your Test Results
Our comprehensive genetic report includes detailed interpretation of your results:
- Positive Result: Indicates presence of pathogenic AGXT gene mutations, requiring immediate consultation with metabolic specialists for management planning
- Negative Result: Suggests absence of known hyperoxaluria type 1 mutations, though continued monitoring may be recommended based on clinical presentation
- Variant of Uncertain Significance: Requires additional family studies and periodic re-evaluation as genetic knowledge advances
- Carrier Status: Important information for reproductive planning and family risk assessment
Test Pricing and Availability
| Test Name | Discount Price | Regular Price |
|---|---|---|
| AGXT Gene Hyperoxaluria Type 1 NGS Genetic DNA Test | $500 USD | $700 USD |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our network of certified genetic counselors and metabolic specialists ensures comprehensive care regardless of your location.
Take Control of Your Metabolic Health Today
Don’t let uncertainty about genetic risks compromise your health and future. Our AGXT Gene Hyperoxaluria Type 1 NGS Genetic DNA Test provides the clarity needed for informed medical decisions and proactive health management. With results available in 3-4 weeks and simple blood sample collection, gaining this vital genetic information has never been more accessible.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic screening appointment. Our dedicated genetic counseling team is ready to guide you through the testing process and help you understand how these results can transform your healthcare journey.
